EGFR and neoplasm: To confirm that our CTC cell line originated from the primary lesion, we previous studies have demonstrated that the sequencing of CTC-TJH-01 cells exhibits wild-type EGFR and a missense mutation at codon 12 in exon 2 of KRAS, which is consistent with the mutation status found in the primary tumor [25].